Analyst Ratings for Phathom Pharmaceuticals (PHAT) [Neutrals]

PHAT Rating Summary

PHAT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PHAT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $56.67 (+60.1%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/12/2021 Goldman Sachs Paul Choi Upgrade Neutral
(Sell)
48.00
(40.00)
32.97
(35.39)
7.34% Details
Like PHAT Ratings? Also take a look at AMRX, TEVA, TRIL, RCKT

PHAT Ratings News